PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
6199318-1	1984	Substituting sarcosine or N-methylalanine for proline in the inhibitory vasopressin analogs dPAVP and d(CH2)5AVP had the following effects: 1) milk ejection and antidiuretic activities were severely depressed, 2) pressor antagonism was maintained but weakened somewhat, and 3) antagonism in the uterus in vitro was maintained, but no consistent pattern was seen.	N-methylalanine	26-41	arginine vasopressin	Homo sapiens	72-83
487287-0	1979	Antagonists of angiotensin II containing N-methyl-L-alanine and DL-nipecotic acid in position 7.	N-methylalanine	41-59	angiotensinogen	Rattus norvegicus	15-29
2871015-1	1986	Resonance Raman (RR) spectra were obtained for the purple complexes of D-amino acid oxidase (DAO) with D-lysine or N-methylalanine.	N-methylalanine	115-130	D-amino acid oxidase	Homo sapiens	71-91
2871015-1	1986	Resonance Raman (RR) spectra were obtained for the purple complexes of D-amino acid oxidase (DAO) with D-lysine or N-methylalanine.	N-methylalanine	115-130	D-amino acid oxidase	Homo sapiens	93-96
3004512-1	1986	To investigate conformations of peptide inhibitors of the angiotensin-converting enzyme in the enzyme-inhibitor complex, the synthesis, studies of inhibitory activity, and conformational calculations of analogues of bradykinin-potentiating peptides with N-methylalanine or D-alanine in place of L-proline or L-alanine residues have been carried out.	N-methylalanine	254-269	kininogen 1	Homo sapiens	216-226
6327326-5	1984	In contrast, the affinity to the hepatic vasopressin receptor, which shares characteristics with vasopressor receptors, was drastically reduced with KD values being in the order proline much less than N- methylalanine less than sarcosine.	N-methylalanine	201-217	arginine vasopressin	Rattus norvegicus	41-52
6187921-0	1983	Synthesis and some pharmacological properties of oxytocin and vasopressin analogues with sarcosine or N-methyl-L-alanine in position 7.	N-methylalanine	102-120	oxytocin/neurophysin I prepropeptide	Homo sapiens	49-57
6187921-0	1983	Synthesis and some pharmacological properties of oxytocin and vasopressin analogues with sarcosine or N-methyl-L-alanine in position 7.	N-methylalanine	102-120	arginine vasopressin	Homo sapiens	62-73
6187921-5	1983	The opposite structure-activity relationship was observed with arginine-vasopressin, where the N-methylalanine-containing analogues were more potent than the sarcosine-containing analogues with respect to pressor activity and also, if not deaminated, with respect to antidiuretic activity.	N-methylalanine	95-110	arginine vasopressin	Homo sapiens	72-83
27790731-9	2016	Specifically, metabolites from the nucleotide and amino acid pathway (ribose, glucose-6-phosphate, glutamic acid, aspartic acid, and sedoheptulose-7-P) were elevated in Shp-/- CD + M mice during the dark cycle, whereas metabolites including N-methylalanine, 2-hydroxybutyric acid, and 2-hydroxyglutarate were elevated in WT ED + E mice during the light cycle.	N-methylalanine	241-256	nuclear receptor subfamily 0, group B, member 2	Mus musculus	169-172